We are live on ! Find out more
TNYA icon

Tenaya Therapeutics
TNYA

76 hedge funds and large institutions have $127M invested in Tenaya Therapeutics in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,425% more call options, than puts

Call options by funds: $101K | Put options by funds: $4K

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

1.97% more ownership

Funds ownership: 71.26% → 73.23% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

4% less funds holding

Funds holding: 79 → 76 (-3)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

55% less capital invested

Capital invested by funds: $280M → $127M (-$153M)

Holders
76
Holders Change
-3
Holders Change %
-3.8%
% of All Funds
1.21%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
32
Reduced
13
Closed
14
Calls
$101K
Puts
$4K
Net Calls
+$97K
Net Calls Change
-$542K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$4.57M
2
BlackRock
BlackRock
New York
+$4.38M
3
RCM
RA Capital Management
Massachusetts
+$2.73M
4
Millennium Management
Millennium Management
New York
+$1.67M
5
Renaissance Technologies
Renaissance Technologies
New York
+$1.42M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$7.47M
2
LGM
Logos Global Management
California
-$3.52M
3
Invesco
Invesco
Georgia
-$2.76M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.38M
5
Marshall Wace
Marshall Wace
United Kingdom
-$494K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
1
Column Group
California
$24M – – –
RCM
2
RA Capital Management
Massachusetts
$17.1M +$2.73M +651,000 +11%
CC
3
Casdin Capital
New York
$16.3M – – –
BlackRock
4
BlackRock
New York
$11.9M +$4.38M +1,047,019 +29%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$11.4M +$23.1K +5,525 +0.1%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$8.13M -$2.38M -567,488 -15%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.53M +$705K +168,489 +8%
Citadel Advisors
8
Citadel Advisors
Florida
$5.37M +$4.57M +1,090,819 +107%
EC
9
Euclidean Capital
New York
$2.59M +$419K +100,000 +11%
AI
10
Alphabet Inc
California
$2.34M – – –
State Street
11
State Street
Massachusetts
$2.24M +$238K +56,865 +7%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.23M +$225K +53,641 +7%
Millennium Management
13
Millennium Management
New York
$1.88M +$1.67M +399,764 +118%
HMC
14
Harvard Management Company
Massachusetts
$1.72M – – –
SG
15
StepStone Group
California
$1.18M – – –
Renaissance Technologies
16
Renaissance Technologies
New York
$1.11M +$1.42M +339,800 +362%
Northern Trust
17
Northern Trust
Illinois
$1.09M +$48.7K +11,625 +3%
GCP
18
GSA Capital Partners
United Kingdom
$927K +$1.01M +240,082 +195%
TOCUITCONY
19
Trustees of Columbia University in the City of New York
New York
$744K – – –
Two Sigma Investments
20
Two Sigma Investments
New York
$642K +$37.6K +8,987 +4%
Barclays
21
Barclays
United Kingdom
$636K +$1.01M +240,436 +2,636%
TD Asset Management
22
TD Asset Management
Ontario, Canada
$561K +$460K +109,966 +100%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$520K +$11.1K +2,650 +1%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$481K +$304K +72,726 +63%
BCM
25
Bridgeway Capital Management
Texas
$464K – – –
1
2 3 4

TNYA Hedge Fund Activity: Q3 2023 in Review

76 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q3 2023, worth a combined $127M — down 55% from $280M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TNYA and 11 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 32 added.

The largest buyer was Citadel Advisors, adding an estimated $4.57M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $7.47M sold.

  • 76 institutional investors held Tenaya Therapeutics (TNYA) as of Q3 2023, down from 79 in Q2 2023.
  • Funds reported $127M of Tenaya Therapeutics stock for Q3 2023, down 55% quarter-over-quarter.
  • 11 funds opened new Tenaya Therapeutics positions in Q3 2023 and 14 closed out, a net change of -3 holders.
  • The largest Tenaya Therapeutics buyer in Q3 2023 was Citadel Advisors, an estimated $4.57M added.
  • The largest Tenaya Therapeutics seller in Q3 2023 was T. Rowe Price Investment Management, an estimated $7.47M sold.

Based on aggregated 13F filings for Q3 2023.